Search research articles
Contact Us
Filters
Showing results (181-190 of 229) with videos related to
Page
of 23
Sort By:
Bioinformatics (Oxford, England)
|
February 15, 2018
Hierarchical analysis of RNA-seq reads improves the accuracy of allele-specific expression
Narayanan Raghupathy, Kwangbom Choi, Matthew J Vincent, et al.
Lancet (London, England)
|
May 7, 1983
Further experience of vitamin supplementation for prevention of neural tube defect recurrences
R W Smithells, N C Nevin, M J Seller, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 13, 1999
Localization and characterization of speech arrest during transcranial magnetic stimulation
C M Epstein, K J Meador, D W Loring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models
Michael J Morowitz, Rosalind Barr, Qun Wang, et al.
Journal of Medicinal Chemistry
|
June 24, 1994
3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists
G S Sheppard, D Pireh, G M Carrera, et al.
Science (New York, N.Y.)
|
October 28, 2006
Thrice out of Africa: ancient and recent expansions of the honey bee, Apis mellifera
Charles W Whitfield, Susanta K Behura, Stewart H Berlocher, et al.
Plos One
|
June 30, 2015
Specificity and Strain-Typing Capabilities of Nanorod Array-Surface Enhanced Raman Spectroscopy for Mycoplasma pneumoniae Detection
Kelley C Henderson, Alvaro J Benitez, Amy E Ratliff, et al.
Molecular Cancer Therapeutics
|
May 28, 2015
MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
Yu Xiao, Paul Nimmer, George S Sheppard, et al.
European Journal of Pharmacology
|
April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist
D H Albert, T J Magoc, P Tapang, et al.
The Journal of Biological Chemistry
|
June 19, 2008
Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activation
Julie L Wilsbacher, Qian Zhang, Lora A Tucker, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 229) with videos related to
Sort By:
Page
of 23
Bioinformatics (Oxford, England)
|
February 15, 2018
Hierarchical analysis of RNA-seq reads improves the accuracy of allele-specific expression
Narayanan Raghupathy, Kwangbom Choi, Matthew J Vincent, et al.
Lancet (London, England)
|
May 7, 1983
Further experience of vitamin supplementation for prevention of neural tube defect recurrences
R W Smithells, N C Nevin, M J Seller, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 13, 1999
Localization and characterization of speech arrest during transcranial magnetic stimulation
C M Epstein, K J Meador, D W Loring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models
Michael J Morowitz, Rosalind Barr, Qun Wang, et al.
Journal of Medicinal Chemistry
|
June 24, 1994
3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists
G S Sheppard, D Pireh, G M Carrera, et al.
Science (New York, N.Y.)
|
October 28, 2006
Thrice out of Africa: ancient and recent expansions of the honey bee, Apis mellifera
Charles W Whitfield, Susanta K Behura, Stewart H Berlocher, et al.
Plos One
|
June 30, 2015
Specificity and Strain-Typing Capabilities of Nanorod Array-Surface Enhanced Raman Spectroscopy for Mycoplasma pneumoniae Detection
Kelley C Henderson, Alvaro J Benitez, Amy E Ratliff, et al.
Molecular Cancer Therapeutics
|
May 28, 2015
MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
Yu Xiao, Paul Nimmer, George S Sheppard, et al.
European Journal of Pharmacology
|
April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist
D H Albert, T J Magoc, P Tapang, et al.
The Journal of Biological Chemistry
|
June 19, 2008
Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activation
Julie L Wilsbacher, Qian Zhang, Lora A Tucker, et al.
Page
of 23